BS

Bhaveshkumar Shankarbhai Detroja

Active Director Designated Partner DIN 10449176
DIN 10449176 First appointment Jan 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhaveshkumar Shankarbhai Detroja

Data last updated:

Bhaveshkumar Shankarbhai Detroja is a Designated Partner at Mbag Firstbio Llp (since 2024).

DIN 10449176
Primary Designation Designated Partner
First Appointment 01 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Jan 20242024Active

Board colleagues of Bhaveshkumar Shankarbhai Detroja

NameDINCompanyDesignation
Chirag Sureshbhai Zalariya10449175Mbag Firstbio LlpDesignated Partner
Girish Chandubhai Patel09818983Mbag Firstbio LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mbag Firstbio Llp
Premium access

Shareholding and investment profile for Bhaveshkumar Shankarbhai Detroja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhaveshkumar Shankarbhai Detroja

Bhaveshkumar Shankarbhai Detroja currently holds 1 directorship: Mbag Firstbio Llp (Designated Partner, since 01 Jan 2024).

Bhaveshkumar Shankarbhai Detroja was first appointed on 01 Jan 2024 as Designated Partner at Mbag Firstbio Llp.

The current boards of Bhaveshkumar Shankarbhai Detroja's companies include Chirag Sureshbhai Zalariya (Mbag Firstbio Llp), Girish Chandubhai Patel (Mbag Firstbio Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available